UW Medicine South Lake Union, University of Washington, Seattle, WA, 98109, USA.
Seattle Children's Research Institute, Center for Developmental Biology & Regenerative Medicine, University of Washington, Seattle, WA, 98105, USA.
Sci Rep. 2018 Dec 14;8(1):17870. doi: 10.1038/s41598-018-35943-x.
Acute kidney injury (AKI) and chronic kidney disease (CKD) are considered early and late phases of a pathologic continuum of interconnected disease states. Although changes in gene expression patterns have recently been elucidated for the transition of AKI to CKD, the epigenetic regulation of key kidney injury related genes remains poorly understood. We used multiplex RT-qPCR, ChIP-qPCR and integrative analysis to compare transcriptional and epigenetic changes at renal disease-associated genes across mouse AKI and CKD models. These studies showed that: (i) there are subsets of genes with distinct transcriptional and epigenetically profiles shared by AKI and CKD but also subsets that are specific to either the early or late stages of renal injury; (ii) differences in expression of a small number of genes is sufficient to distinguish AKI from CKD; (iii) transcription plays a key role in the upregulation of both AKI and CKD genes while post-transcriptional regulation appears to play a more significant role in decreased expression of both AKI and CKD genes; and (iv) subsets of transcriptionally upregulated genes share epigenetic similarities while downregulated genes do not. Collectively, our study suggests that identified common transcriptional and epigenetic profiles of kidney injury loci could be exploited for therapeutic targeting in AKI and CKD.
急性肾损伤 (AKI) 和慢性肾脏病 (CKD) 被认为是相互关联的疾病状态病理连续体的早期和晚期阶段。尽管最近已经阐明了 AKI 向 CKD 转变过程中基因表达模式的变化,但关键肾脏损伤相关基因的表观遗传调控仍知之甚少。我们使用多重 RT-qPCR、ChIP-qPCR 和综合分析来比较小鼠 AKI 和 CKD 模型中与肾脏疾病相关基因的转录和表观遗传变化。这些研究表明:(i) AKI 和 CKD 具有共享的具有不同转录和表观遗传特征的基因亚组,但也有一些基因亚组仅存在于肾脏损伤的早期或晚期;(ii) 少数基因的表达差异足以区分 AKI 和 CKD;(iii) 转录在 AKI 和 CKD 基因的上调中起关键作用,而转录后调控似乎在 AKI 和 CKD 基因的下调中起更重要的作用;以及 (iv) 转录上调基因的亚组具有相似的表观遗传特征,而下调基因则没有。总的来说,我们的研究表明,鉴定出的肾脏损伤基因座的共同转录和表观遗传特征可用于 AKI 和 CKD 的治疗靶向。